AbCellera Biologics Inc. (NASDAQ:ABCL) has 144 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 31 Mar, 2026 | 30,275,938 | 2,750,298 | 9.99% | $105,663,024.00 |
| BAKER BROS. ADVISORS LP | 31 Mar, 2026 | 27,525,640 | 0 | 0.00% | $94,137,689.00 |
| Capital World Investors | 31 Mar, 2026 | 13,361,096 | 0 | 0.00% | $45,694,948.00 |
| Capital World Investors | 31 Mar, 2026 | 13,361,096 | 0 | 0.00% | $46,630,225.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Mar, 2026 | 10,562,065 | 4,751,080 | 81.76% | $36,861,607.00 |
| TD Waterhouse Canada Inc. | 31 Mar, 2026 | 9,564,659 | 9,542,247 | 42,576.51% | $33,569,696.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 8,688,970 | 8,438,753 | 3,372.57% | $29,716,278.00 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 31 Mar, 2026 | 7,876,629 | 7,876,629 | 0.00% | $26,938,071.00 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 31 Mar, 2026 | 7,575,476 | -301,153 | -3.82% | $26,438,411.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Mar, 2026 | 5,810,985 | 635,843 | 12.29% | $19,873,569.00 |
| TWO SIGMA ADVISERS, LP | 31 Mar, 2026 | 4,878,000 | 78,100 | 1.63% | $16,682,760.00 |
| UBS Group AG | 31 Mar, 2026 | 4,209,052 | 2,269,643 | 117.03% | $14,689,591.00 |
| ArrowMark Colorado Holdings LLC | 31 Mar, 2026 | 4,105,095 | 0 | 0.00% | $14,326,782.00 |
| ArrowMark Colorado Holdings LLC | 31 Mar, 2026 | 4,105,095 | 0 | 0.00% | $14,039,425.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 4,040,236 | 174,340 | 4.51% | $14,100,423.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 4,024,779 | 252,780 | 6.70% | $14,046,479.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 3,865,896 | 224,117 | 6.15% | $13,221,366.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 3,771,999 | 2,045,058 | 118.42% | $12,900,237.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 3,751,212 | -4,937,758 | -56.83% | $13,091,730.00 |
| Morgan Stanley | 31 Mar, 2026 | 3,001,850 | 209,708 | 7.51% | $10,266,329.00 |